Vishal Sikri
Presidente presso Inivata Ltd.
Patrimonio netto: 2 M $ in data 31/05/2024
Posizioni attive di Vishal Sikri
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Inivata Ltd.
 Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Presidente | 23/05/2022 | - |
Storia della carriera di Vishal Sikri
Precedenti posizioni note di Vishal Sikri
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NEOGENOMICS, INC. | Corporate Officer/Principal | 23/05/2022 | 15/04/2024 |
Formazione di Vishal Sikri
| Beloit College | Undergraduate Degree |
| University of Wisconsin | Graduate Degree |
| Loyola University of Chicago | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Regno Unito | 2 |
Posizioni
| President | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 4 |
| Technology Services | 2 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NEOGENOMICS, INC. | Health Services |
| Aziende private | 1 |
|---|---|
Inivata Ltd.
Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Borsa valori
- Insiders
- Vishal Sikri
- Esperienza
